Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00302133Phase 2Completed
Phase 2, randomised, double-blind trial of naltrexone in alcohol dependence, sponsored by University of Miami. Primary endpoint: Mean Number of Standard Drinks Per Drinking Day During the Last 4 Weeks of the Trial at 12 weeks. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00302133.